[Strategies for discontinuing immunotherapy in patients with inflammatory bowel disease]

MMW Fortschr Med. 2021 Apr;163(8):68-71. doi: 10.1007/s15006-021-9800-3.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Humans
  • Immunologic Factors
  • Immunotherapy
  • Inflammatory Bowel Diseases* / therapy

Substances

  • Immunologic Factors